SOURCE: Antisoma plc

January 07, 2010 07:07 ET

Antisoma to present at J.P. Morgan Healthcare Conference

LONDON--(Marketwire - January 7, 2010) -

07 January 2010, London, UK, and Cambridge, MA: Antisoma plc (LSE: ASM; USOTC: ATSMY) announces that its Chief Executive Officer, Glyn Edwards, will present an overview of the Company's strategy, programmes and prospects at the 28th Annual J.P. Morgan Healthcare Conference in San Francisco, on Thursday, January 14th at 11:30 PST/19:30 GMT.

A webcast of the presentation will be available on Antisoma's website at

For live viewing of the webcast, it is recommended that viewers log on 15 minutes early in order to register and download any necessary software.

Daniel Elger
VP, Marketing and Communications
Antisoma plc
+44 (0) 20 3249 2100

Background on Antisoma

Antisoma is a London Stock Exchange-listed biopharmaceutical company that develops novel products for the treatment of cancer. The Company has operations in the UK and the US. Please visit for further information about Antisoma.


Contact Information